TP53 and ovarian cancer: Additionally, THs may alter intracellular trafficking and the phosphorylation of TR, ERα, Stat1 and p53, through the integrin αvβ3 pathway [27] and nuclear interaction of Stat1 with the integrin αv monomer in ovarian cancer cells [18].